Choosing an Australian Sponsor for Your Medical Device: What to Look For

Once you’ve established that you need an Australian Sponsor, and most overseas manufacturers do, the next question is who to choose. The Sponsor you appoint will hold legal regulatory responsibility for your device in Australia, appear on your product labelling, and be your first point of contact when the TGA comes knocking. Getting this decision right matters far more than most manufacturers realise. Here’s a practical framework for evaluating your options.

Why the Choice of Sponsor Matters More Than You Think

The Australian Sponsor is not a passive administrative role. Under the Therapeutic Goods Act 1989, your Sponsor holds ongoing legal responsibilities for your device’s compliance in Australia, from the initial ARTG application through to post-market surveillance, adverse event reporting, and TGA audit responses. A Sponsor who is slow, poorly resourced, or unfamiliar with your device type isn’t just an inconvenience. They are a regulatory liability.

The practical consequences of a poor Sponsor choice tend to emerge not at the point of initial registration, where the process is relatively straightforward, but later, when something goes wrong. A TGA audit request lands and your Sponsor doesn’t know where your technical documentation is. A serious adverse event occurs and your Sponsor misses the 2-business-day reporting window. Your Notified Body certificate lapses and nobody flags it to the TGA. These are the moments when the quality of your Sponsor relationship becomes critically important.

The good news is that evaluating Sponsor candidates is straightforward if you know what to look for. The following seven criteria give you a practical framework for making the right choice.

1. Genuine Australian Presence — Not Just a Registered Address

The TGA requires that an Australian Sponsor be either a resident of Australia or an incorporated body carrying out business in Australia. In practice, this requirement is easy to satisfy on paper and many international regulatory firms maintain a nominal Australian entity for exactly this purpose. What it does not guarantee is a Sponsor with genuine local engagement: people who know the TGA’s current expectations, attend industry events, and pick up the phone during Australian business hours.

For manufacturers with higher-risk devices, or those anticipating TGA audits or post-market scrutiny, a Sponsor with genuine boots-on-the-ground Australian presence is meaningfully different from one managing your account remotely from Europe or North America. The TGA is a relatively small regulator so relationships matter, local knowledge matters, and response times during Australian hours matter.

✔ Practical tip: Ask any Sponsor candidate directly: where is your Australian team based, and who specifically will be handling my account day-to-day? A credible answer names specific people in specific Australian locations, not a generic reference to ‘our Australian office’.

2. Regulatory Expertise Matched to Your Device Type

Australian Sponsor services are offered by a wide range of providers, from large multinational regulatory consultancies to smaller boutique firms to individual consultants. What varies enormously between them is the depth of expertise they bring to specific device types and regulatory pathways.

A Sponsor who primarily handles straightforward Class I and Class IIa devices will have a very different level of competence when it comes to a Class III implantable or a software-as-a-medical-device than one who works regularly across all device classifications. Similarly, a Sponsor with deep EU MDR expertise is meaningfully better placed to leverage your CE Marking for an abridged TGA pathway than one who processes applications without understanding the underlying technical documentation.

Relevant questions to ask a prospective Sponsor:

• What device classes do you most commonly work with? Do you have experience with devices at my classification level?
• Have you handled TGA applications for devices similar to mine by type, technology, or intended purpose?
• Do you have experience with the abridged pathway for EU MDR-certified or FDA-cleared devices?
• Have you managed TGA audit responses for higher-risk devices? What was the outcome?

⚠ Watch out: Be cautious of Sponsors who give vague answers about their experience or who cannot point to specific examples of devices they have registered at your classification level. Regulatory experience is specific. A track record with Class I devices does not translate automatically to competence with Class III.

3. Commercial Independence

One of the most structurally important decisions you will make is whether your Sponsor is commercially independent from your distribution arrangements in Australia. This single factor has more downstream implications than almost any other aspect of the Sponsor relationship.

When a distributor acts as Sponsor, your ARTG listings are legally tied to that distributor. If the commercial relationship ends, whether by your choice, theirs, or simply because a better distribution partner emerges, the ARTG entries must be formally transferred to a new Sponsor. This involves a TGA transfer process, potential relabelling of your products (since the Sponsor’s name appears on labels), and a gap period during which supply arrangements may be disrupted. In some cases, manufacturers have found themselves commercially constrained and reluctant to change a distributor precisely because of the regulatory complexity of unwinding the Sponsor arrangement.

An independent professional Sponsor has no commercial interest in your Australian sales. They provide regulatory services for a fee, and their continued engagement depends on the quality of that service, not on maintaining a distribution relationship. This gives you full freedom to appoint, change, or expand your commercial partners in Australia without any regulatory disruption.

Key question to ask yourself: If my distribution arrangements in Australia changed tomorrow (new distributor, multiple distributors, or direct supply) how would that affect my ARTG listings? If the answer is ‘significantly’, your Sponsor structure deserves a review.

✔ Practical tip: Even if you currently have a single Australian distributor and no plans to change, building your Sponsor arrangement around commercial independence from the outset is almost always worth the modest additional cost. Changing Sponsor arrangements retroactively is significantly more disruptive than getting the structure right the first time.

4. Post-Market Capability — Not Just Registration

Many manufacturers evaluate Sponsor candidates almost entirely on their ability to get devices onto the ARTG, the initial registration process. This is understandable, but it misses the point. ARTG inclusion is a one-time event. Post-market compliance is ongoing, potentially for the lifetime of the product, and it’s where the quality of your Sponsor relationship is most consistently tested.

A capable Sponsor needs robust systems for:

Adverse Event and Vigilance Reporting

The TGA’s reporting timeframes are strict. Serious adverse events may require reporting within 2 business days of the Sponsor becoming aware. Missing these windows is a compliance failure with real consequences. Ask prospective Sponsors directly about their vigilance reporting processes: do they have documented procedures, who is responsible, and what is their track record?

Manufacturer Evidence Maintenance

Your ARTG listings are linked to your Manufacturer Evidence, typically your EU MDR Notified Body certificate. When that certificate is renewed, suspended, or updated, the TGA must be notified and the ME updated. A Sponsor who doesn’t have a system for tracking ME currency is a Sponsor who will eventually let your ARTG listings lapse without warning.

TGA Audit and Inspection Responses

For higher-risk device classes, TGA audits involve substantive review of technical documentation — clinical evaluation reports, risk management files, post-market surveillance data. A Sponsor who cannot competently coordinate an audit response, or who doesn’t understand your technical documentation well enough to present it effectively, puts your ARTG listing at risk.

Regulatory Change Monitoring

Australian medical device regulations continue to evolve; new guidance documents, UDI implementation milestones, changes to ARTG fee structures, and TGA enforcement priorities all affect your obligations. A proactive Sponsor keeps you informed of changes that affect your devices. A passive one waits for you to ask.

✔ Practical tip: Ask prospective Sponsors for an example of a post-market issue they have managed for a client — an adverse event report, a TGA query response, or an ME update. How they answer this question tells you more about their post-market capability than any service description will.

5. Transparency on Scope and Fees

Australian Sponsor service pricing varies considerably across the market, and fee structures are not always straightforward. Some providers charge a low headline fee for Sponsor appointment but apply significant additional charges for services that are, in practice, routinely required — adverse event reporting, ARTG entry updates, label reviews, ME renewals, and TGA correspondence. Others bundle services comprehensively but at a higher base cost.

Neither model is inherently wrong. What matters is that you understand exactly what is and is not included in your Sponsor agreement before you sign it. The questions to ask upfront:

• What is included in the base Sponsor fee, and what triggers additional charges?
• How is adverse event and vigilance reporting handled — is it included, or charged per report?
• What is the process and cost for updating ARTG entries when device changes occur?
• Are TGA audit responses included in scope, or are they billed separately?
• How is fee escalation handled — are annual increases capped or defined in the agreement?
• What are the exit terms if we need to transfer to a different Sponsor?

⚠ Watch out: Be particularly cautious of agreements that are vague on the scope of post-market services. A Sponsor engagement that appears cost-effective at registration can become significantly more expensive when routine post-market activities attract per-incident charges. Get the fee structure in writing and in specific terms before committing.

6. Understanding of Your Existing International Approvals

For overseas manufacturers entering the Australian market with existing CE Marking or FDA clearance, the Sponsor’s understanding of those international approvals is directly relevant to the quality and efficiency of your TGA application. A Sponsor who understands EU MDR technical documentation can accurately assess how your existing CE file maps to Australian requirements, identify genuine gaps rather than flagging non-issues, and structure your ARTG application to leverage your existing evidence most effectively.

A Sponsor without this expertise may treat every Australia-specific requirement as a major documentation exercise — adding cost and time to a process that, for well-prepared EU MDR-certified manufacturers, should be straightforward. Conversely, a Sponsor who doesn’t understand the limits of what the TGA will accept on the basis of CE Marking alone may underestimate genuine gaps and create compliance issues down the line.

This is particularly relevant for:

• Classification assessments — ensuring your Australian classification is confirmed rather than assumed from your EU or US classification
• Essential Principles mapping — accurately mapping your GSPR checklist to the Australian framework rather than rebuilding it from scratch
• Clinical evidence assessment — understanding what your EU MDR clinical evaluation documentation covers for TGA purposes, and where additional Australian-specific evidence may be needed
• UDI compliance — understanding how your EU MDR UDI implementation maps to Australia’s AusUDID requirements

✔ Practical tip: If you hold CE Marking under EU MDR 2017/745, look specifically for a Sponsor with demonstrable EU MDR expertise — not just general TGA experience. The two frameworks interact directly in the abridged pathway, and a Sponsor who understands both will produce a faster, more robust TGA application.

7. A Named, Accountable Contact. Not a Service Desk

This criterion sounds soft, but its practical implications are real. The Sponsor’s name and address appear on your product labelling. In the event of a TGA audit, recall, or adverse event investigation, the Sponsor is the party the TGA contacts first. In a time-sensitive compliance situation, and many are, the difference between a named specialist who knows your device and a rotating service desk that needs to look up your account is the difference between a competent response and a compliance failure.

A Sponsor who assigns a named regulatory professional to your account, who knows your device history, your documentation structure, and your distribution arrangements, is structurally more capable of managing issues effectively than one who handles your account as an anonymous ticket in a queue.

Ask any prospective Sponsor: who specifically will be my primary contact, what is their regulatory background, and what is the coverage arrangement if that person is unavailable?

The Questions to Ask Before Appointing a Sponsor

To summarise the framework above, here are the key questions to put to any prospective Australian Sponsor before signing an agreement:

• Where is your Australian team physically located, and who will be my named account contact?
• What device classes and types do you most commonly work with? Can you give examples of devices you have registered at my classification level?
• Are you commercially independent from distributors in Australia? Do you have any financial interest in the sale of devices you sponsor?
• How do you handle adverse event reporting? What are your internal procedures and timeframes?
• How do you track and manage Manufacturer Evidence renewals and updates?
• Have you managed TGA audit responses for Class IIb or Class III devices? Can you describe how that process works?
• What is included in your base fee, and what triggers additional charges?
• What are your exit terms if we need to transfer Sponsorship?
• Do you have experience with the abridged TGA pathway for EU MDR-certified or FDA-cleared devices?

A credible, experienced Sponsor will answer all of these questions specifically and confidently. Vague or evasive answers to any of them should be treated as a warning sign.

Why Manufacturers Choose Practical RA

Practical RA is a Melbourne-based boutique regulatory firm providing Australian Sponsor services to overseas manufacturers of medical devices and IVDs. Our Australian Sponsor service is built on the criteria outlined in this guide: genuine local presence, technical depth across device classifications, full commercial independence, robust post-market systems, and transparent scoping.

Our Australian Sponsor practice is led by Tara Silva, a regulatory specialist with direct experience from a large multinational firm who brings both technical depth and genuine TGA relationships to the role. As a boutique firm, we do not manage accounts through a service desk. Manufacturers work with named specialists who know their devices.

Critically, Practical RA’s expertise spans EU MDR 2017/745, US FDA, and TGA requirements. For manufacturers approaching the Australian market with existing CE Marking or FDA clearance, this means we understand your existing documentation and can assess your TGA pathway accurately and efficiently without treating every aspect of the process as unfamiliar territory.

If you’re evaluating Australian Sponsor options, we’re happy to have an initial conversation at no charge. Contact our team or reach out to Tara directly at tara@practicalra.com.

Ready to discuss your Australian Sponsor options? Contact Practical RA for a no-charge initial conversation about your device’s TGA pathway and what to expect from a professional Sponsor relationship.

Key Takeaways

• The Sponsor you choose holds ongoing legal responsibility for your device’s compliance in Australia — the decision matters well beyond initial registration
• Evaluate candidates across seven criteria: genuine Australian presence, device-specific expertise, commercial independence, post-market capability, fee transparency, understanding of your international approvals, and named accountability
• Commercial independence — using a Sponsor not tied to your distributor — provides critical flexibility if your Australian commercial arrangements change
• Post-market capability is where Sponsor quality is most consistently tested: ask about adverse event reporting procedures, ME renewal tracking, and audit experience
• For EU MDR-certified manufacturers, a Sponsor with EU MDR expertise will produce a more efficient and accurate TGA application than one without it
• Always get fee scope in writing before signing — understand specifically what is and is not included in the base engagement